Trinity Biotech plc to Announce First Quarter Fiscal Year

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Trinity Biotech plc to Announce First Quarter Fiscal Year 2015 Financial Results

DUBLIN, Ireland, April 23, 2015 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB ), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the first quarter fiscal year 2015 on Thursday, April 30, 2015. The Company has scheduled a conference call for that same day, Thursday, April 30, 2015 at 11:00am ET (4:00pm BST) to discuss the results of the quarter.

Interested parties can access the call by dialing:

USA: 1-888-243-4451
International: 1-412-542-4135
Conference ID #: 10064828

A simultaneous webcast of the call can be accessed at: http://www.videonewswire.com/event.asp?id=102224

A replay of the call can be accessed until May 7, 2015 by dialing:

USA: 1-877-344-7529
International: 1-412-317-0088
Conference ID #: 10064828

The webcast of the call will be available for 30 days at: http://www.videonewswire.com/event.asp?id=102224

About Trinity Biotech plc

Trinity Biotech develops, acquires, manufactures and markets diagnostic systems, including both reagents and instrumentation, for the point-of-care and clinical laboratory segments of the diagnostic market. The products are used to detect infectious diseases and to quantify the level of Haemoglobin A1c and other chemistry parameters in serum, plasma and whole blood. Trinity Biotech sells direct in the United States, Germany, France and the U.K. and through a network of international distributors and strategic partners in over 75 countries worldwide. For further information please see the Company's website: www.trinitybiotech.com .

Forward-looking statements in this release are made pursuant to the "safe harbor" provision of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties including, but not limited to, the results of research and development efforts, the effect of regulation by the United States Food and Drug Administration and other agencies, the impact of competitive products, product development commercialisation and technological difficulties, and other risks detailed in the Company's periodic reports filed with the Securities and Exchange Commission.

Kevin Tansley Trinity Biotech plc (353)-1-2769800 E-mail: Joe Diaz, Joe Dorame and Robert Blum Lytham Partners, LLC Investor Relations 602-889-9700

Scroll down for more posts ▼

Top 10 Most Recent News Articles

TransDigm Surges Ahead with Strong Q4 and FY Results

Updated Category News Views 54

TransDigm's Impressive Performance in Fiscal 2026 Here's a company that's really kicking it up a notch—TransDigm Group (NYSE:TDG) just reported some solid fourth-quarter numbers that scream growth. Net sales soared to $2,988 million, marking a 23% hike from last year's fourth quarter of $2,437 million. That's a cool $551 million leap, quite the party for shareholders....

Continue Reading
Ebix Relaunches A.D.A.M. SmartCare Platform for Clinicians

Updated Category News Views 118

Revolutionizing Patient Education with SmartCare When you're in the thick of things, juggling a half-dozen patients with different needs all in a day’s work, you want your tools to be as fast and straightforward as a greasy spoon diner breakfast—simple, satisfying, and utterly dependable. And Ebix is betting they've cooked up just the recipe for that with their...

Continue Reading
HSF Opens Scholar Program to All Ethnicities

Updated Category News Views 339

Redefining Eligibility for Inclusive Progress Picture this: the landscape of educational support shifting towards inclusivity. The Hispanic Scholarship Fund (HSF), long a champion for Hispanic educational advancement, is taking a bold step by opening its doors wider. From January 2027, the HSF Scholar Program will embrace students of all backgrounds, a massive leap away...

Continue Reading
Hansa Bolsters Financials with SERB Deal, Eyes Growth

Updated Category News Views 17

Financial Gains and Strategic Shifts Oh, here we go again—another quarterly report from Hansa Biopharma, and this one’s got some meat on its bones. They’ve sparked up their financial engine with a hefty €115 million licensing deal with SERB, which is a real shot in the arm. As any investor worth their salt would see, this isn’t just about piling cash. It's...

Continue Reading
Ampace Showcases Safety-First Battery Tech for AI Data Centers

Updated Category News Views 27

PU200's Debut: Making Safety and Space Work in Tandem Ever noticed how safety's become the name of the game for data center operations? Powered by the influx of AI, these digital fortresses crave robust power backup, and Ampace’s stepping in with their PU200 UPS battery solution at Data Centre World Paris 2026. Showing off at Hall 5, Booth M65, Ampace's bringing to the...

Continue Reading
Entenmann's Packs Seasonal Joy into Limited-Time Treats

Updated Category News Views 52

Winter Treats Stepping into the Limelight Another year, another holiday season descended upon us—the calorie indulgence is real, folks. There’s something criminally comforting about these recurring flavors, especially when Entenmann’s and Little Bites decide it’s time to drop some trademark nostalgia into the frosty mix. Pop these limited-edition sweets on your...

Continue Reading
Wood Partners Commences on 301-Unit Alta Meadowlands

Updated Category News Views 103

Planting the Seeds for Alta Meadowlands It's all systems go for Wood Partners and GrayCo as they kick off construction on Alta Meadowlands in Hillsborough, North Carolina. Now, this isn't just another boxy warehouse masquerading as an apartment complex. We're talking a real commitment to shaking up the local real estate scene—a 301-unit community right in the...

Continue Reading
Envista's $430M Senior Notes: A Market Move Decoded

Updated Category News Views 114

Envista on the Move with $430M Notes Ever feel like the market's a bit like a rollercoaster with no brakes? That's kind of where we're at with Envista Holdings Corporation (NYSE: NVST) rolling out this new financial play. They just priced a hefty $430 million in Senior Notes at a solid 6.250% due 2033. In terms of the investment world, that's a pretty big splash. The...

Continue Reading
AEWIN Unveils Powerful Servers with AMD EPYC Chips

Updated Category News Views 83

AEWIN's Bold Move in Server Tech Hang onto your hats, folks, 'cause AEWIN Technologies just took its server game to a whole new level. During the AMD in Depth: EPYC "Venice" event in Las Vegas, AEWIN, nestled neatly under the Qisda Group umbrella, hit the market with hardware that's bound to turn heads—both literally and figuratively. With their latest server offerings...

Continue Reading
MIT Study: Reinforced Masonry Slashes Hurricane Damage

Updated Category News Views 87

Building Smarter: Concrete vs. The Storm Hurricanes are nature’s wrecking balls, and if there’s one thing the latest MIT study tosses on the table, it’s that reinforced concrete masonry isn't just holding its ground—it's changing the game. You see, when Hurricane Irma swung through Florida, it left a clear message written in the rubble: smarter building means...

Continue Reading

Top 5 Most Recently Viewed Articles

Rivian's Strategic Expansion with Volkswagen Boosts EV Journey

Updated Category News Views 300

Rivian and Volkswagen Strengthen Their Collaboration Recent discussions between Volkswagen and Rivian highlight the potential for an expanded partnership that may greatly impact the electric vehicle (EV) industry. Volkswagen’s CEO, Oliver Blume, recently commented on the exciting opportunities presented by this collaboration, which focuses on leveraging shared resources...

Continue Reading
Investigation Announced for TransMedics Group, Inc. Investors

Updated Category News Views 199

Investigation into TransMedics Group, Inc. Announced The Rosen Law Firm, a prominent legal practice dedicated to defending investor rights, has recently initiated an investigation regarding potential securities claims on behalf of shareholders of TransMedics Group, Inc. (NASDAQ: TMDX). This move follows serious allegations that the company may have provided materially...

Continue Reading
Significant Regulatory Challenges for Telix Pharmaceuticals Unfold

Updated Category News Views 145

Regulatory Challenges for Telix Pharmaceuticals Telix Pharmaceuticals Ltd. (NASDAQ: TLX) is currently navigating through difficult regulatory waters, prompting investors to rethink their positions. A recent reminder issued by the well-regarded national law firm Hagens Berman highlights the mounting issues surrounding the company's prostate cancer drug, TLX591, and its...

Continue Reading
Invest Green Acquisition Corp Secures $172.5 Million IPO Success

Updated Category News Views 233

Invest Green Acquisition Corporation Celebrates IPO Achievement Invest Green Acquisition Corporation is thrilled to announce the successful closing of its initial public offering, which raised an impressive $172.5 million. This achievement represents the sale of 17,250,000 units at a price of $10.00 per unit. The offering included the exercise of an overallotment option...

Continue Reading
Anticipated Growth in Automotive Suspension Market by 2034

Updated Category News Views 135

Significant Growth Anticipated in the Automotive Suspension Sector The global automotive suspension shock absorber market is forecasted to grow remarkably from USD 31.5 billion to USD 45.2 billion over the next decade, with an average annual growth rate of 4.0%. This surge reflects evolving consumer priorities towards enhanced comfort, safety, and advanced vehicle...

Continue Reading